| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 3 275-282, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
Y Lun, M Sawadogo and M Perry
Department of Biochemistry, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Members of the MyoD family of muscle-specific transcription factors play central roles in the formation and differentiation of skeletal muscle; however, steps involved in the initiation and subsequent regulation of myogenic factor expression are poorly understood. To investigate mechanisms underlying muscle cell type-specific MyoD gene expression, the functions of regulatory elements that control Xenopus MyoDa gene transcription were analyzed. We show that E boxes in the XMyoDa promoter have dual functions. These sites bind myogenic basic helix-loop-helix proteins and serve as target sites for direct autoactivation. In addition, these regulatory elements bind other, more widely expressed proteins that repress promoter activity. In particular, the binding of the transcriptional regulatory protein USF to a conserved site in the XMyoDa promoter decreased basal activity of the promoter and inhibited MyoD-dependent autoactivation. The results suggest that XMyoD transcription and myogenic factor activity is governed by a competition between muscle-specific, positive-acting factors and widely expressed repressors for binding to common regulatory sites.
This article has been cited by other articles:
![]() |
Md. M. Ali, T. Yoshizawa, O. Ishibashi, A. Matsuda, M. Ikegame, J. Shimomura, H. Mera, K. Nakashima, and H. Kawashima PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts J. Cell Sci., August 1, 2007; 120(15): 2565 - 2573. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang and C. R. Mendelson O2 Enhancement of Human Trophoblast Differentiation and hCYP19 (Aromatase) Gene Expression Are Mediated by Proteasomal Degradation of USF1 and USF2 Mol. Cell. Biol., October 15, 2005; 25(20): 8824 - 8833. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Daniels and G. K. Andrews Dynamics of the metal-dependent transcription factor complex in vivo at the mouse metallothionein-I promoter Nucleic Acids Res., December 1, 2003; 31(23): 6710 - 6721. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang and C. R. Mendelson USF1 and USF2 Mediate Inhibition of Human Trophoblast Differentiation and CYP19 Gene Expression by Mash-2 and Hypoxia Mol. Cell. Biol., September 1, 2003; 23(17): 6117 - 6128. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Yang, L. A. Freeman, C. L. Knapper, M. J. A. Amar, A. Remaley, H. B. Brewer Jr., and S. Santamarina-Fojo The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene J. Lipid Res., February 1, 2002; 43(2): 297 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Providence, L. A. White, J. Tang, J. Gonclaves, L. Staiano-Coico, and P. J. Higgins Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene J. Cell Sci., January 10, 2002; 115(19): 3767 - 3777. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Samoylenko, U. Roth, K. Jungermann, and T. Kietzmann The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxia-inducible factor-1 binding site Blood, May 1, 2001; 97(9): 2657 - 2666. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Vallet, M. Casado, A. A. Henrion, D. Bucchini, M. Raymondjean, A. Kahn, and S. Vaulont Differential Roles of Upstream Stimulatory Factors 1 and 2 in the Transcriptional Response of Liver Genes to Glucose J. Biol. Chem., August 7, 1998; 273(32): 20175 - 20179. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |